Hyderabad Telangana, India

Prem Kumar Mamnoor


Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Andhra Pradesh, IN (2000)
  • Hyderabad, IN (2004)

Company Filing History:


Years Active: 2000-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Prem Kumar Mamnoor

Introduction

Prem Kumar Mamnoor is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anti-inflammatory and anti-ulcer properties. His work has led to the filing of two patents that showcase his innovative approach to drug formulation.

Latest Patents

Mamnoor's latest patents include "Compounds having anti-inflammatory activity: process for their preparation and pharmaceutical compositions containing them." This invention relates to novel heterocyclic compounds and their various forms, including derivatives and pharmaceutically acceptable compositions. Another significant patent is "Benzimidazole derivatives as antiulcer agents, process for their preparation." This invention focuses on novel pyridylmethylsulfinyl benzimidazole and its derivatives, emphasizing their potential use in pharmaceutical applications.

Career Highlights

Throughout his career, Mamnoor has worked with prominent organizations such as Dr. Reddy's Laboratories and Dr. Reddy's Research Foundation. His experience in these institutions has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Rajagopalan Ramanujam and Manojit Pal. Their collaboration has likely fostered an environment of innovation and creativity in their respective projects.

Conclusion

Prem Kumar Mamnoor's contributions to the field of pharmaceuticals through his patents and career achievements highlight his role as an influential inventor. His work continues to impact the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…